Stephanie Blencke

An efficient proteomics method to identify the cellular targets of protein kinase inhibitors

Klaus Godl, Josef Wissing, Alexander Kurtenbach et al. · Proceedings of the National Academy of Sciences · 2003 · 334 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Cellular Targets of Gefitinib

Dirk Brehmer, Zoltán Greff, Klaus Godl et al. · Cancer Research · 2005 · 239 citations · Full text

Medicine, Oncology, Pharmacology +16

Identification of SRPK1 and SRPK2 as the Major Cellular Protein Kinases Phosphorylating Hepatitis B Virus Core Protein

Henrik Daub, Stephanie Blencke, Peter Habenberger et al. · Journal of Virology · 2002 · 148 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +8

Characterization of a Conserved Structural Determinant Controlling Protein Kinase Sensitivity to Selective Inhibitors

Stephanie Blencke, Birgit Zech, Ola Engkvist et al. · Chemistry & Biology · 2004 · 142 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +8

Phosphosignature Predicts Dasatinib Response in Non-small Cell Lung Cancer

Martin Klammer, Marc Kaminski, Alexandra Zedler et al. · Molecular & Cellular Proteomics · 2012 · 120 citations · Full text

Medicine, Oncology, Pharmacology +17